Skip to main content
. 2022 Jan 26;13:817526. doi: 10.3389/fphar.2022.817526

FIGURE 4.

FIGURE 4

Punicalagin alleviates psoriasis by inhibiting NF-κB-mediated IL-1β transcription and caspase-1-regulated IL-1β secretion. Punicalagin relieves psoriasis by inhibiting NF-κB activation and cleaved caspase-1 expression, which ultimately suppresses the transcription and secretion of IL-1β and consequently represses IL-1β-mediated inflammatory cascade in vitro and in vivo.